(Q37947082)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

The cytochrome P450 pathway in angiogenesis and endothelial cell biology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Ingrid Fleming

series ordinal

1

1 reference

25 August 2017

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

Cancer and Metastasis Reviews

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

541-555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10555-011-9302-3

14 January 2020

exact match

0 references

cites work

Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Molecular circuits of resolution in the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Novel 14S,21-dihydroxy-docosahexaenoic acid rescues wound healing and associated angiogenesis impaired by acute ethanol intoxication/exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Epoxyeicosatrienoic acids and endothelium-dependent responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

cDNA cloning and expression of a soluble epoxide hydrolase from human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Central role of peroxisomes in isoprenoid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Polymorphisms in human soluble epoxide hydrolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 2C is an EDHF synthase in coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Post-receptor signal transduction and regulation of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125i-14,15-epoxyeicosa-8(Z)-enoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Action of epoxyeicosatrienoic acids on cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP(2) receptors in rat mesenteric artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

EDHF: bringing the concepts together

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Agonist-induced Ca2+ influx into human platelets is secondary to the emptying of intracellular Ca2+ stores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Synergistic activation of vascular TRPC6 channel by receptor and mechanical stimulation via phospholipase C/diacylglycerol and phospholipase A2/omega-hydroxylase/20-HETE pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

TRPV4 calcium entry channel: a paradigm for gating diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Eicosapentaenoic acid increases cytochrome P-450 2J2 gene expression and epoxyeicosatrienoic acid production via peroxisome proliferator-activated receptor γ in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

11,12-Epoxyeicosatrienoic acid stimulates tyrosine kinase activity in porcine aortic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase/Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Direct eicosanoid profiling of the hypoxic lung by comprehensive analysis via capillary liquid chromatography with dual online photodiode-array and tandem mass-spectrometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Role of Cytochrome P-450 in Alveolar Hypoxic Pulmonary Vasoconstriction in Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 isozymes and antiepileptic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 2C9-induced angiogenesis is dependent on EphB4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Inhibitors of cytochrome P450 4A suppress angiogenic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Soluble epoxide hydrolase inhibition modulates vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Contribution of epoxyeicosatrienoic acids to the hypoxia-induced activation of Ca2+ -activated K+ channel current in cultured rat hippocampal astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome p450 epoxygenase promotes human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Oxidative metabolism of tamoxifen to Z-4-hydroxy-tamoxifen by cytochrome P450 isoforms: an appraisal of in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Cytochrome P450-derived eicosanoids: the neglected pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The resolution of inflammation: the devil in the flask and in the details

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

n-3 Fatty acids block TNF-α-stimulated MCP-1 expression in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienz

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Impact of n-3 fatty acids on endothelial function: results from human interventions studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

Diminished omega-3 fatty acids are associated with carotid plaques from neurologically symptomatic patients: Implications for carotid interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9302-3

10.1007/S10555-011-9302-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22009065%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference